Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues

Research output: Contribution to journalJournal articlepeer-review


  • Fulltext

    Final published version, 5.28 MB, PDF document

Environmental and genetic factors cause defects in pancreatic islets driving type 2 diabetes (T2D) together with the progression of multi-tissue insulin resistance. Mass spectrometry proteomics on samples from five key metabolic tissues of a cross-sectional cohort of 43 multi-organ donors provides deep coverage of their proteomes. Enrichment analysis of Gene Ontology terms provides a tissue-specific map of altered biological processes across healthy, prediabetes (PD), and T2D subjects. We find widespread alterations in several relevant biological pathways, including increase in hemostasis in pancreatic islets of PD, increase in the complement cascade in liver and pancreatic islets of PD, and elevation in cholesterol biosynthesis in liver of T2D. Our findings point to inflammatory, immune, and vascular alterations in pancreatic islets in PD that are hypotheses to be tested for potential contributions to hormonal perturbations such as impaired insulin and increased glucagon production. This multi-tissue proteomic map suggests tissue-specific metabolic dysregulations in T2D.

Original languageEnglish
Article number100763
JournalCell Reports Medicine
Issue number10
Number of pages21
Publication statusPublished - 2022

Bibliographical note

Publisher Copyright:
© 2022 The Author(s)

    Research areas

  • liver, mass spectrometry, multi-tissue, pancreatic islets, prediabetes, proteomics, skeletal muscle, T2D, type 2 diabetes, visceral adipose tissue

ID: 324172333